Forward-Looking Statements Investor Presentation Second Quarter 2025 Earnings August 6, 2025 August 2025 / © 2025 Remitly Inc. Disclosures This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements. These statements include, but are not limited to, statements regarding our future events or our future results of operations and financial position, includ ...

Core Insights - Semler Scientific, Inc. has reported significant progress in its Bitcoin treasury strategy, purchasing approximately $195.4 million of Bitcoin, bringing total holdings to nearly $586.2 million as of July 31, 2025, with unrealized gains exceeding $110.4 million and a BTC yield of 31.3% year-to-date [2][9][10] - The company launched CardioVanta™, a subsidiary focused on healthcare initiatives for early detection of heart failure and cardiac arrhythmia, positioning itself as a dual-engine platform for growth [2][26] - Financial results for Q2 2025 show revenues of $8.2 million, a 43% decrease year-over-year, and a net income of $66.9 million, significantly up from $11 thousand in Q2 2024 [10][11] Bitcoin Treasury Highlights - As of June 30, 2025, Semler Scientific held 4,636 Bitcoins valued at $496.9 million, reflecting a cumulative increase in fair value of $66.9 million [9][10] - The company purchased 1,444 Bitcoins for $149.6 million during Q2 2025 and an additional 385 Bitcoins for $45.8 million through July 31, 2025 [9][10] - Total Bitcoin holdings as of July 31, 2025, reached 5,021 Bitcoins with a fair value of $586.2 million [9][10] Financial Performance - Total operating expenses for Q2 2025 were $10.3 million, compared to $9.1 million in Q2 2024, with a loss from operations of $2.1 million [10][11] - Pre-tax income for Q2 2025 was $80.6 million, influenced by an unrealized gain of $83.8 million from Bitcoin holdings [10][11] - The effective tax rate for Q2 2025 was 17%, compared to 99% in Q2 2024 [10][11] Customer Concentration - The two largest customers accounted for 45% and 31% of Q2 2025 revenues, while the three largest customers in Q2 2024 accounted for 44%, 27%, and 11% of revenues [5][10] Cash Flow and Financing Activities - The company reported a net cash increase of $4.7 million for the period, with significant cash flows from financing activities, including $156.9 million from the issuance of common stock [13][10] - Semler Scientific has entered into a new Controlled Equity OfferingSM Sales Agreement allowing it to issue up to $500 million in common stock [9][10]

Company Overview - Arch Capital Group Ltd provides insurance, reinsurance, and mortgage insurance worldwide through its subsidiaries[1] - The company's financial strength ratings include AA- from Standard & Poor's and A+ from A M Best Company[2] Financial Highlights - Total Gross Premiums Written reached $22.9 billion[2] - Total Assets amounted to $78.8 billion[2] - Total Net Reserves were $23.6 billion[2] - Total Capitalization stood at $25.8 billion[2] - Net Premiums Written were divided among Reinsurance (48% or $7.9 billion), Insurance (46% or $7.7 billion), and Mortgage (6% or $1.1 billion)[2] Capitalization Trend - Total Capitalization increased from $15.6 billion in 2021 to $25.8 billion in 2025[4] Operating Income - Operating Income for the trailing 12 months ending June 30, 2025, was $3.194 billion[6] - The Operating Income Return on Average Equity for the trailing 12 months ending June 30, 2025, was 15.2%[6] Investment Portfolio - The investment portfolio includes Corporates (34.3%), U S Gov't and Gov't Agencies (26.7%), and Equity method funds & other (17.9%)[11]

Core Viewpoint - Waterdrop Inc. reported strong financial and operational growth in the first quarter of 2025, with significant increases in revenue and profit compared to previous periods [3][10]. Financial and Operational Highlights - Net operating revenue for Q1 2025 increased by 7.0% year-over-year to RMB 753.7 million (US$ 103.9 million) and by 9.7% quarter-over-quarter [9]. - Net profit attributable to ordinary shareholders reached RMB 108.2 million (US$ 14.9 million), marking a 34.2% year-over-year increase [10][15]. - First-year premiums generated through the insurance business reached RMB 2,092.4 million (US$ 288.3 million), representing a 19.3% year-over-year increase [10]. - Insurance-related income amounted to RMB 658.0 million (US$ 90.7 million), an increase of 8.4% year-over-year [11]. - Digital clinical trial solution income grew by 11.5% year-over-year to RMB 23.0 million (US$ 3.2 million) [12]. Insurance Business Performance - The insurance business saw a 30.1% year-over-year increase in short-term insurance premiums [4]. - Long-term insurance premiums grew by 27.6% quarter-over-quarter, indicating operational resilience despite product iteration challenges [4]. Crowdfunding and Risk Management - Waterdrop Medical Crowdfunding expanded its verification platform to cover 92% of domestic cities, enhancing risk control and campaign validation processes [5]. - Cumulatively, around 475 million people donated an aggregate of RMB 68.8 billion to 3.47 million patients through the crowdfunding platform [10]. AI and Technology Integration - The penetration of 'AI Insurance Expert - Medical Insurance' facilitated over RMB 2 million in monthly premiums [7]. - The 'AI Service Quality Copilot' improved unit operational efficiency by 83% since its launch [7]. Shareholder Value and Cash Position - The company distributed approximately US$ 7.3 million in cash dividends and repurchased around 54.2 million ADSs for a total consideration of approximately US$ 106.6 million as of May 31, 2025 [8][18]. - As of March 31, 2025, the cash position was RMB 3,543.3 million (US$ 488.3 million) [17].

Core Viewpoint - Zhibao Technology Inc. has revised its financial results for the six months ended December 31, 2024, showing a decreased net loss compared to previous reports, indicating improved financial performance [1][2]. Financial Adjustments - The company made adjustments to its income statement, resulting in a net loss of RMB0.6 million ($0.09 million) for the six months ended December 31, 2024, down from a previously reported net loss of RMB1.5 million ($0.2 million) [2]. - The adjusted basic and diluted GAAP loss per share was RMB0.02 ($0.00), compared to the previously reported RMB0.05 ($0.01) [2]. Balance Sheet Revisions - The revised unaudited condensed consolidated balance sheet showed a decrease in convertible notes from RMB6,888,414 to RMB6,452,341 and an addition of warrant liabilities amounting to RMB1,239,814 [4]. - Total current liabilities increased to RMB235,018,593, and total liabilities rose to RMB242,206,924 after adjustments [4]. Income Statement Changes - Net interest expense increased from RMB1.4 million ($0.2 million) to RMB1.6 million ($0.2 million) [6]. - A gain from the fair value change of warrant liabilities was added, amounting to RMB1.4 million ($0.2 million) [6]. - The loss on settlement of convertible notes increased from RMB4.1 million ($0.5 million) to RMB4.4 million ($0.6 million) [6]. Comprehensive Loss - The comprehensive loss for the six months ended December 31, 2024, was adjusted to RMB1,008,750, down from RMB1,906,027 [8]. - The company projects a 70% revenue growth and improvements in gross profit, profit from operations, and net income for the fiscal year ending June 30, 2025, compared to the same period last year [8]. Company Overview - Zhibao Technology Inc. is a leading InsurTech company in China, primarily providing digital insurance brokerage services [10]. - The company has developed over 40 innovative digital insurance solutions and partnered with over 2,000 business channels, serving more than 20 million end customers [11].

Core Viewpoint - InMode Ltd. is set to release its financial results for the first quarter of 2025 on April 28, 2025, with preliminary revenue expectations ranging from $77.2 million to $77.5 million and a projected non-GAAP gross margin of 78% to 79% [6][2]. Financial Results - The company anticipates first quarter 2025 revenue to be between $77.2 million and $77.5 million [6]. - The projected non-GAAP gross margin for the same period is expected to be in the range of 78% to 79% [6]. - For the full year 2025, InMode expects revenue to be between $395 million and $405 million [6]. Conference Call Details - A conference call to discuss the first quarter 2025 financial results will take place on April 28, 2025, at 8:30 a.m. Eastern Daylight Time [3]. - Key management personnel, including the CEO, CFO, and CTO, will present during the call [3]. - Participants are encouraged to pre-register for the call to receive unique dial-in information [4]. Company Overview - InMode is recognized as a leading global provider of innovative medical technologies, focusing on devices that utilize novel radio frequency technology [6][7]. - The company aims to enhance surgical procedures and improve existing treatments across various medical fields, including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology [6][7].